These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid]. Meinardi MC, van den Berg GB, Groenhuijzen A, Driessen JT, Maas HA, Wolfhagen FH. Ned Tijdschr Geneeskd; 2008 Feb 02; 152(5):278-82. PubMed ID: 18333544 [Abstract] [Full Text] [Related]
23. Hyperammonaemic encephalopathy and a flat electroencephalogram caused by valproic acid. Belze O, Remérand F, Pujol A, Fusciardi J. Acta Anaesthesiol Scand; 2013 Sep 02; 57(8):1084. PubMed ID: 23713766 [No Abstract] [Full Text] [Related]
24. A severe valproate overdose with complete recovery in a newborn. Grynnerup A, Fernández IS, Hernández JC, Martínez AD, López JM, García-Alix A. J Child Neurol; 2012 Aug 02; 27(8):1072-6. PubMed ID: 22433424 [Abstract] [Full Text] [Related]
25. Severe hyperammonaemic encephalopathy resulting from the overlap between hepatic and valproate encephalopathy. Izadi Firouzabadi L, Geer K, Mead P, Paul Mead. Postgrad Med J; 2018 Nov 02; 94(1117):664. PubMed ID: 30397004 [No Abstract] [Full Text] [Related]
27. Valproate-induced hyperammonemic encephalopathy: a brief review. Lewis C, Deshpande A, Tesar GE, Dale R. Curr Med Res Opin; 2012 Jun 02; 28(6):1039-42. PubMed ID: 22587482 [Abstract] [Full Text] [Related]
29. Hyperammonemic encephalopathy related to valproate, phenobarbital, and topiramate synergism. Gomez-Ibañez A, Urrestarazu-Bolumburu E, Viteri-Torres C. Epilepsy Behav; 2011 Aug 02; 21(4):480-2. PubMed ID: 21700501 [Abstract] [Full Text] [Related]
32. [Valproate-associated hyperammonemic encephalopathy. Report of one case]. Young P, Finn BC, Alvarez F, Bruetman JE, Trimarchi H. Rev Med Chil; 2007 Nov 02; 135(11):1446-9. PubMed ID: 18259656 [Abstract] [Full Text] [Related]